Representatives passed legislation to better protect all patients who use cannabis medically, the WSLCB subpoena bill gets a hearing, and the House meets Saturday (as the Senate rests).
Senators unanimously passed a bill that may ban all CBD products in Washington state, and legislators would reconvene on Friday to potentially vote on two cannabis bills.
To ensure the safety of youth, senators unanimously agreed any amount of THC in a hemp product was too much as they amended and passed a bill to age gate products containing THC.
Two more cannabis bills were pulled out of Senate Rules, interstate was passed by senators, the schedule for next week has some surprises, and floor activity continues.
Two amendments added “sideboards” and data analysis to legislation to modify and expand social equity licensing; Senators gave favorable remarks before passing the bill.
Three cannabis bills were passed in their house of origin on Tuesday, while on Wednesday senators could pull up to six cannabis bills out of Rules and potentially take action on interstate.
The board got a status update on legislation, discussed an impending social equity licensing window, and learned about a new format for staff guidance on rulemaking petitions.
Cannabis-related bills were not taken up by legislators on Monday, but the social equity bill was moved out of rules, joining three other bills ready for second and third readings.
At the first work group meeting, members introduced themselves and heard agency leaders’ intentions to gather input on the effectiveness of 2022 cannabis testing changes.
After the house of origin fiscal committee cutoff, 18 cannabis bills remained active—one less than expected—as legislators prepared for floor debate over the next week and a half.
